Dimitar N.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- A Pharmacokinetic and Safety Study of Bimekizumab via Different Routes of Administration in Adults with Chronic Cutaneous Inflammation
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Enpatoran for Active Cutaneous Lupus Erythematosus (with or without systemic disease)
- Phase III Randomized Double‑Blind Placebo‑Controlled Trial of Elecoglipron (AZD5004) on Renal Decline and Mortality in Adults with Chronic Kidney Disease
Data & Insights
Has run more than one trial at 235 of 652 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in treating systemic lupus erythematosus (SLE) and its variants, including cutaneous lupus erythematosus (CLE). Their research encompasses both moderate and severe manifestations of these conditions.
- Systemic Lupus Management
- Cutaneous Lupus Treatment
- Novel Therapeutic Approaches
Additional focus includes rheumatoid arthritis and axial spondyloarthritis treatment strategies.
Nephrology
Expertise in treating chronic kidney disease (CKD) with particular attention to complications such as albuminuria and proteinuria. The investigator works with innovative therapeutic combinations to address kidney function decline.
- CKD Management
- Proteinuria Treatment
- Renal Function Preservation
Special interest in kidney disease associated with hypertension.
Treatment Innovation
The investigator evaluates biosimilar medications and explores combination therapies for complex medical conditions. Their work includes assessment of both established and emerging treatment modalities.
- Novel Drug Combinations
- Biological Therapies
- Long-term Treatment Outcomes
Focus on developing therapeutic strategies for treatment-resistant conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.